Tech Company Financing Transactions
Avagenesis Funding Round
Avagenesis closed a venture capital round on 12/21/2013. Investors included private investors.
Transaction Overview
Company Name
Announced On
12/21/2013
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1500 West Georgia St. 3rd Floor
Vancouver BC, V6G 2Z6
Canada
Vancouver BC, V6G 2Z6
Canada
Phone
Website
Email Address
Overview
Avagenesis is a pioneering cellular bioprocessing company that through its revoluntionary technology is able to isolate cellular components from autologous human tissue for use in the field of medical aesthetics and cellular therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Norman Tsui
Chief Financial Officer
Shui Tam
Chief Scientific Officer
Chris Chang
Chief Technical Officer
Richard Huang
Browse more venture capital transactions:
Prev: 12/21/2013: Encore Vision venture capital transaction
Next: 12/21/2013: Kidizen venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs